LifeOnKey, Inc.

LifeOnKey, Inc. is a healthcare technology company that leverages AI to enhance personalized patient care through its innovative INTEGRA platform, designed for use in various healthcare settings. Founded in 2007 and headquartered in New York, US, LifeOnKey, Inc. focuses on providing advanced healthcare solutions.

The company successfully raised USD 5 mn in Series A funding in December 2007, which was fully utilized to support its operational strategies. The founder, Moshe Farin, has a background in technology and healthcare, contributing significant expertise to the company’s mission. The current CEO is Linda Harnevo. LifeOnKey primarily offers the INTEGRA platform, an AI-enhanced solution designed to facilitate personalized healthcare across various settings, including hospitals, clinics, and health insurance providers.

The platform integrates applications for monitoring chronic diseases, enabling both health professionals and patients to engage actively in their care. Key features include a Medical Rule Engine that allows for automated data analysis and alerts, a Research Platform that aggregates anonymous health data for decision support, and a Personal Health Platform that empowers individuals to access and manage their health information via mobile applications and web interfaces. The INTEGRA platform is utilized by a diverse client base, including healthcare institutions and providers in North America and Europe, who benefit from its innovative tools to improve patient care and outcomes. LifeOnKey operates under a Software as a Service (SaaS) subscription model, allowing clients to access the INTEGRA platform and its associated applications without hefty upfront costs.

Clients, which include hospitals and healthcare organizations, pay a fixed monthly fee that encompasses state-of-the-art hosting, implementation, training, and ongoing support. This transactional structure is designed for flexibility and affordability, ensuring that organizations can swiftly implement advanced healthcare technology. As part of this model, institutions benefit from a comprehensive package that includes various features and functionalities tailored to enhance patient monitoring and engagement within their healthcare workflows. LifeOnKey intends to expand its product offerings by developing additional applications for the INTEGRA platform aimed at specific chronic disease management in the next 12 months.

The company is also targeting expansion into the European healthcare market, aiming for entry by early 2025. The recent funding of USD 5 mn will be strategically employed to support product development and market entry initiatives.